Legislature(2017 - 2018)BARNES 124
04/18/2018 01:00 PM House RESOURCES
Note: the audio
and video
recordings are distinct records and are obtained from different sources. As such there may be key differences between the two. The audio recordings are captured by our records offices as the official record of the meeting and will have more accurate timestamps. Use the icons to switch between them.
| Audio | Topic |
|---|---|
| Start | |
| HB28 | |
| Adjourn |
* first hearing in first committee of referral
+ teleconferenced
= bill was previously heard/scheduled
+ teleconferenced
= bill was previously heard/scheduled
| *+ | HB 28 | TELECONFERENCED | |
| + | TELECONFERENCED |
HB 28-COSMETICS INGREDIENTS DISCLOSURE
1:03:43 PM
CO-CHAIR TARR announced that the only order of business would be
HOUSE BILL NO. 28, "An Act relating to the disclosure of the
ingredients in cosmetics; and providing for an effective date."
CO-CHAIR TARR handed the gavel to Co-Chair Josephson and
presented HB 28 as prime sponsor. She spoke to the labeling and
regulation of cosmetics, personal care products, and drugs. She
gave the example of anti-dandruff shampoo, which is regulated as
both a cosmetic and as a drug. She presented a PowerPoint on
"House Bill 28 - Cosmetic Ingredient Disclosure" [included in
committee packet]. She said that some slides were from the
Campaign for Safe Cosmetics.
CO-CHAIR TARR pointed to the list of "Chemicals of Concern" on
slide 7:
• SODIUM LAURYL/LAURETH SULFATE (SLS AND SLES)
• PETROLEUM/PARAFFIN/MINERAL OIL
• FORMALDEHYDE
• HYDROQUINONE
• MERCURY (THIMEROSAL AND MERTHIOLATE)
• PARABENS (ISOBUTYLPARABEN, BUTYLPARABEN,
METHYLPARABEN, PROPYLPARABEN)
• PHTHALATES (DBP, DEHP, DEP)
• SYNTHETIC FRAGRANCE/PARFUM
• PROPYLENE GLYCOL
• TRICLOSAN
CO-CHAIR TARR drew attention to parabens and phthalates,
which were further examined on slide 8. She pointed out
which products the compounds are found in, the related
health concerns, what to look for on the label, and related
regulations.
1:12:10 PM
CO-CHAIR TARR stated that there is more research in the European
Union on chemicals than in U.S. She said that even though there
is no ban, there is pressure to change from the use of some of
the compounds by consumer demand.
CO-CHAIR TARR spoke to the health concerns due to exposure to
chemicals, listed on slide 10:
• Cancer
• Reproductive Health disorders
• Developmental toxicity
• Allergies
• Endocrine disruption
• Immunotoxicity
• Neurodevelopmental disorders
CO-CHAIR TARR spoke to the use of cosmetics in cancer
patients and pregnant women. She underlined the necessity
to label products which may be unsafe, particularly for
consumers with health needs.
1:19:11 PM
CO-CHAIR TARR stated the bill would require all ingredients be
listed on the manufacturer web site. She highlighted that it
would not require lists to be present on products as it would
increase costs to businesses.
REPRESENTATIVE BIRCH asked whether there would be a threshold
number of the elements.
CO-CHAIR TARR pointed to page 1, lists 9 through 12. She
paraphrased from the section, which read as follows:
9 (b) The list of ingredients in (a) of this
section must list the ingredients in
10 descending order of the predominance of each
ingredient in the cosmetic, except that a
11 manufacturer may list an ingredient without
respect to order of predominance if the
12 ingredient is present in the cosmetic at a
concentration of one percent or less.
CO-CHAIR TARR spoke to fillers. She said that inexpensive
herbal supplements can contain fillers. She added that in China
lead can be used in glazes for houseware products. She stated
that for endocrine disruptors, even limited exposure is a
problem.
REPRESENTATIVE BIRCH asked whether the motivation for the
proposal was due to erroneous labeling.
CO-CHAIR TARR answered the biggest difference concerns
fragrances. She said some products may have phthalates, but
only list fragrances.
1:24:49 PM
CO-CHAIR JOSEPHSON suggested that with the proposal,
manufacturer would have to list more elements; however, consumer
would have to be vigilant about looking at the labels.
CO-CHAIR TARR added that some retailers are self-regulating.
CO-CHAIR JOSEPHSON mentioned other current legislation which
would require the state to be more vigilant about oversight of
wholesale pharmaceuticals. He referred to a study carried out
in the state which showed the chemical blueprint of individual
consumers. He asked whether those chemicals stay in the system.
CO-CHAIR TARR answered that some chemicals bind with fat cells
and are expelled over time. She added that another study had
found chemicals in breast milk of far North mothers which found
chemicals not available in the area due to pollution in the air.
She mentioned persistent organic pollutants (POPs).
REPRESENTATIVE RAUSCHER asked why the elements are not already
required.
CO-CHAIR TARR answered the federal laws are outdated. She
stated that the earlier belief was that some of the chemicals
were not a problem. She said recent studies are being carried
out to more fully understand the effects.
1:31:11 PM
REPRESENTATIVE RAUSCHER asked how far behind the federal
government is in establishing similar requirements.
CO-CHAIR TARR suggested business interests can make changes
difficult. She said states are taking action and may prompt
federal action. She reiterated that new information is
available today.
REPRESENTATIVE RAUSCHER asked where to find out what is in the
products he purchases if they are not listed on the packaging.
1:35:21 PM
CO-CHAIR TARR pointed to the web sites in slide 13. She said
overall health is based on multiple factors. She referred to
cancer survivors and the need to be aware of ingredients in
cosmetics.
REPRESENTATIVE DRUMMOND said she is interested in Alaska-made
products. She mentioned a soap company in her area which makes
its products using good ingredients."
CO-CHAIR TARR added that cosmetic regulations are over 75 years
old. She mentioned that it is a major industry.
1:41:04 PM
[HB 28 was held over.]
| Document Name | Date/Time | Subjects |
|---|---|---|
| HB028 Sponsor Statement 4.17.2018.pdf |
HRES 4/18/2018 1:00:00 PM |
HB 28 |
| HB028 Version A 4.17.18.PDF |
HRES 4/18/2018 1:00:00 PM |
HB 28 |
| HB028 Sectional Analysis 4.17.18.pdf |
HRES 4/18/2018 1:00:00 PM |
HB 28 |
| HB 28 Fiscal Note - DEC-EH 4.13.18.pdf |
HRES 4/18/2018 1:00:00 PM |
HB 28 |
| HB 28 cosmetic disclosure - sponsor presentation 4.18.18.pdf |
HRES 4/18/2018 1:00:00 PM |
HB 28 |